Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer

NCT00750555 is registered in ClinicalTrials.gov with Geisinger Clinic as lead sponsor.

NCT NCT00750555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00750555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer
Lead sponsor
Geisinger Clinic
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2008
Completion date
December 31, 2009
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer